Publicaciones en las que colabora con MARIO FERNANDEZ FRAGA (13)

2024

  1. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. Circulating miRNA expression in long-standing type 1 diabetes mellitus

    Scientific Reports, Vol. 13, Núm. 1

2014

  1. Role of BRD4 in hematopoietic differentiation of embryonic stem cells

    Epigenetics, Vol. 9, Núm. 4, pp. 566-578

2013

  1. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma

    Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950

  2. Aging epigenetics: Causes and consequences

    Molecular Aspects of Medicine, Vol. 34, Núm. 4, pp. 765-781

  3. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  4. The role of genetics in the establishment and maintenance of the epigenome

    Cellular and Molecular Life Sciences, Vol. 70, Núm. 9, pp. 1543-1573

2012

  1. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 14, pp. 2270-2281

  2. Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer

    Journal of Molecular Medicine, Vol. 90, Núm. 5, pp. 587-595

  3. De novo DNA methyltransferases: Oncogenes, tumor suppressors, or both?

    Trends in Genetics, Vol. 28, Núm. 10, pp. 474-479

  4. Discovery of salermide-related sirtuin inhibitors: Binding mode studies and antiproliferative effects in cancer cells including cancer stem cells

    Journal of Medicinal Chemistry, Vol. 55, Núm. 24, pp. 10937-10947

2010

  1. A possible role for epigenetics in age-dependent bone diseases

    Clinical Reviews in Bone and Mineral Metabolism, Vol. 8, Núm. 2, pp. 95-99

  2. Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer

    Molecular Cancer, Vol. 9